{"id":1853,"date":"2008-01-19T09:24:05","date_gmt":"2008-01-19T13:24:05","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=1853"},"modified":"2008-01-19T09:24:05","modified_gmt":"2008-01-19T13:24:05","slug":"dermatosis-perforante-adquirida","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/1853","title":{"rendered":"Dermatosis perforante adquirida"},"content":{"rendered":"<p><strong>Breve revisi\u00f3n de dermatosis perforante realizada por la DRa. Mildred S\u00e1nchez, egresada en dermatolog\u00eda, en diciembre del 2007 de la cohorte del Instituto de Dermatolog\u00eda- Hospital Vargas de Caracas &#8211; Venezuela&nbsp;<\/strong><\/p>\n<p>Enfermedades perforantes: Grupo de trastornos papulonodulares, tejido conjuntivo es&nbsp; eliminado a trav\u00e9s de la dermis. <\/p>\n<ul>\n<li>Colagenosis Perforante Reactiva.<\/li>\n<li>Elastosis Perforante Serpiginosa<\/li>\n<li>Dermatosis Perforante adquirida<\/li>\n<li>Foliculitis perforante o Enf de Kyrle.<\/li>\n<\/ul>\n<p><!--more--><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/residente1.jpg\" alt=\"residente1.jpg\" \/> <\/p>\n<p>______________<br \/> <em>Rapini, R. Enfermedades perforantes en Dermatologia. Bolognia J, Jorizzo J, Rapini R. 1ra Edici\u00f3n. 2004.1497-1502<\/em><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/residente2.jpg\" alt=\"residente2.jpg\" \/> <\/p>\n<ul>\n<li>Se desarrolla en adultos<\/li>\n<li>Relacionados con enfermedades sist\u00e9micas (82,4%). Insuficiencia renal (72,7%). DM (50%). Hepatitis C, hipotiroidismo, TBC<\/li>\n<li>Cl\u00ednicamente p\u00e1pulas umbilicadas o n\u00f3dulos con centro necr\u00f3ticos.<\/li>\n<li>Prurito<\/li>\n<li>Principalmente en MsIs<\/li>\n<\/ul>\n<p> _______________<br \/> <em>&#8211; Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis. Report of six cases and review of the literature. J Am Acad Dermatol. 1994 Apr;30(4):575-80.<br \/> &#8211; Kovich O Acquired perforating disorder. Dermatol Online J. 2004 Nov 30;10(3):16.<\/em><\/p>\n<p> <\/p>\n<ul>\n<li>Histopatolog\u00eda no uniforme, puede semejar a las otras dermatosis perforantes<\/li>\n<li>Hiperqueratosis con paraqueratosis variable, Material amorfo degradado en el interior de las perforaciones sin posibilidad de identificar como fibras de col\u00e1genos o el\u00e1sticas.<\/li>\n<\/ul>\n<p> <img decoding=\"async\" src=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/2007\/12\/184\/residente3.jpg\" alt=\"residente3.jpg\" \/><br \/> ________________<br \/> &nbsp;&#8211; Saray Y, Se&ccedil;kin D, Bilezik&ccedil;i B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases.J Eur Acad Dermatol Venereol. 2006 Jul;20(6):679-88.<\/p>\n<p> <strong>BIBLIOGRAFIA<\/strong><br \/> &#8211; Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis. Report of six cases and review of the literature. J Am Acad Dermatol. 1994 Apr;30(4):575-80.<br \/> &#8211; Kovich O Acquired perforating disorder. Dermatol Online J. 2004 Nov 30;10(3):16.<br \/> &#8211; Saray Y, Se&ccedil;kin D, Bilezik&ccedil;i B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases.J Eur Acad Dermatol Venereol. 2006 Jul;20(6):679-88.<br \/> &#8211; Gambichler T, Altmeyer P, Kreuter A. Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol. 2004 Jun;50(6):892-4.<br \/> &#8211; G&ouml;n&uuml;l M, Cakmak SK, G&uuml;l U, Kili&ccedil; A, Erg&uuml;l G. Two cases of acquired perforating dermatosis treated with doxycycline therapy. Int J Dermatol. 2006 Dec;45(12): 1461-3.<br \/> &#8211; Hoque SR, Ameen M, Holden CA. Acquired reactive perforating collagenosis: four patients with a giant variant treated with allopurinol.Br J Dermatol. 2006 Apr;154(4):759-62.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Breve revisi\u00f3n de dermatosis perforante realizada por la DRa. Mildred S\u00e1nchez, egresada en dermatolog\u00eda, en diciembre del 2007 de la cohorte del Instituto de Dermatolog\u00eda- Hospital Vargas de Caracas &#8211; Venezuela&nbsp; Enfermedades perforantes: Grupo de trastornos papulonodulares, tejido conjuntivo es&nbsp; eliminado a trav\u00e9s de la dermis. Colagenosis Perforante Reactiva. Elastosis Perforante Serpiginosa Dermatosis Perforante adquirida &hellip;<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[],"class_list":["post-1853","post","type-post","status-publish","format-standard","","category-fichas-bibliograficas"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/1853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=1853"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/1853\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=1853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=1853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=1853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}